BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28365416)

  • 41. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy.
    Mitsutake R; Miura S; Sako H; Nishikawa H; Saku K
    Int J Cardiol; 2008 Sep; 129(2):e61-3. PubMed ID: 17888532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Bach RG; Leach C; Milov SA; Lindsay BD
    J Invasive Cardiol; 2006 Jun; 18(6):E176-8. PubMed ID: 16775896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy.
    Efthimiadis GK; Meditskou S; Vassilikos V; Hadjimiltiades S; Styliadis IH; Parcharidis GE
    Swiss Med Wkly; 2008 May; 138(21-22):322; author reply 322-3. PubMed ID: 18578089
    [No Abstract]   [Full Text] [Related]  

  • 46. Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Cooper RM; Binukrishnan SR; Shahzad A; Hasleton J; Sigwart U; Stables RH
    EuroIntervention; 2017 Apr; 12(18):e2194-e2203. PubMed ID: 27890861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracardiac echocardiography guidance for alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Alfonso F; Martín D; Fernández-Vázquez F
    J Invasive Cardiol; 2007 May; 19(5):E134-6. PubMed ID: 17470972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: the perfect septal branch may originate from an atypical location.
    Noble S; Frangos C; L'allier PL
    Can J Cardiol; 2012; 28(2):245.e1-3. PubMed ID: 22277780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol septal ablation in hypertrophic cardiomyopathy. 3D contrast echocardiography allows localization and quantification of the extension of intraprocedural vascular recruitment.
    Moya Mur JL; Salido Tahoces L; Mestre Barceló JL; Rodríguez Muñoz D; Hernández R; Fernández-Golfín C; Zamorano Gómez JL
    Int J Cardiol; 2014 Jul; 174(3):761-2. PubMed ID: 24767762
    [No Abstract]   [Full Text] [Related]  

  • 50. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4D Computed Tomography Visualization of Effective Septal Reduction After Alcohol Septal Ablation for Fatal Hypertrophic Obstructive Cardiomyopathy.
    Akita K; Kaneko Y; Sato R; Iguchi K; Suwa K; Maekawa Y
    Circ J; 2022 Mar; 86(4):725. PubMed ID: 34853278
    [No Abstract]   [Full Text] [Related]  

  • 52. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
    Crossen K; Jones M; Erikson C
    Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.
    Nagueh SF; Groves BM; Schwartz L; Smith KM; Wang A; Bach RG; Nielsen C; Leya F; Buergler JM; Rowe SK; Woo A; Maldonado YM; Spencer WH
    J Am Coll Cardiol; 2011 Nov; 58(22):2322-8. PubMed ID: 22093510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Coronary fistula of the right ventricular outflow tract as a complication of combined transaortic-trans-right ventricular myectomy in hypertrophic obstructive cardiomyopathy].
    Buchwald A; Wiegand V; Kreuzer H
    Z Kardiol; 1988 Jan; 77(1):61-3. PubMed ID: 3363981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
    Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.
    Rigopoulos AG; Sakellaropoulos S; Ali M; Mavrogeni S; Manginas A; Pauschinger M; Noutsias M
    Heart Fail Rev; 2018 Nov; 23(6):907-917. PubMed ID: 29736811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alcohol septal ablation after failed surgical myectomy.
    Joyal D; Arab D; Chen-Johnston C; Leya F
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):999-1002. PubMed ID: 17525959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
    Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 60. Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.
    Maekawa Y; Jinzaki M; Tsuruta H; Akita K; Yamada Y; Kawakami T; Hayashida K; Yuasa S; Murata M; Fukuda K
    Int J Cardiol; 2015 Feb; 181():349-50. PubMed ID: 25555276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.